Atrius Limited closes $1 million Series A Preferred Stock Financing

RESEARCH TRIANGLE PARK, August 15, 2014: Atrius Limited, a Synecor spinout company developing a novel, less invasive access system that facilitates percutaneous Transmitral transcatheter mitral valve replacement, announced today that it closed a $1.0 million Series A Preferred Stock financing led by Piedmont Capital Partners, LLC of Greensboro, N.C. Atrius Limited will be managed by William Starling and Richard Stack, MD.

Leave a Reply

Your email address will not be published.